A conjoined universal helper epitope can unveil antitumor effects of a neoantigen vaccine targeting an MHC class I-restricted neoepitope
Abstract Personalized cancer vaccines targeting neoantigens arising from somatic missense mutations are currently being evaluated for the treatment of various cancers due to their potential to elicit a multivalent, tumor-specific immune response. Several cancers express a low number of neoantigens;...
Guardado en:
Autores principales: | Adam M. Swartz, Kendra L. Congdon, Smita K. Nair, Qi-Jing Li, James E. Herndon, Carter M. Suryadevara, Katherine A. Riccione, Gary E. Archer, Pamela K. Norberg, Luis A. Sanchez-Perez, John H. Sampson |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/630d5dbd82df4a1bb95d08b2e6228b95 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Reversion analysis reveals the in vivo immunogenicity of a poorly MHC I-binding cancer neoepitope
por: Hakimeh Ebrahimi-Nik, et al.
Publicado: (2021) -
Self-assembled conjoined-cages
por: Sagarika Samantray, et al.
Publicado: (2020) -
Pan-cancer analysis of neoepitopes
por: Gabriel N. Teku, et al.
Publicado: (2018) -
Agreement with conjoined arguments in Kuria
por: Michael Diercks, et al.
Publicado: (2015) -
Heteropagus conjoined twins: Five cases
por: Mahamat-nour Abakar Djibrine, et al.
Publicado: (2022)